Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 江西三鑫医疗科技股份有限公司(原江西三鑫医疗器械集团有限公司)是专业从事医疗器械研发、制造和销售的国家高新技术企业,公司创建于1997年3月,坐落在国家经济百强县-南昌县,是通过CE、CMD质量管理体系和产品认证及美国FDA510(K)上市许可的国家一次三类性医疗器械定点生产企业。公司总部地处江西南昌小蓝经济开发区,有两大生产厂区.公司拥有"义鑫"、"三鑫"和"鑫港"三个产品注册商标,义鑫商标2010年被国家工商总局认定为"中国驰名商标";主要产品有:"义鑫"和"三鑫"牌一次性使用无菌医疗器械.如:注射类系列[常规注射器、自毁式注射器、防针剌式自毁注射器等]、输液类系列[常规输液器、滴定管式输液器、袋式输液器、非PVC输液器、精密调节输液器、避光输液器、延长管等]、留置针、中心静脉导管、血液透析系列[针、管、液、器]等4大系列30余个品种1000多种型号规格的国内注册或已经受理注册的产品。
Main Business 一次性使用无菌注输类医疗器械的研发、生产和销售，医疗设备租赁。
Legal Representative 彭义兴
Top Executives
董事长：彭义兴
副董事长：雷凤莲
董事：乐珍荣,刘明,毛志平,雷凤莲
独立董事：蒋海洪,陈国锋,夏晓华
Top 5 Shareholder
Shareholder name Nature Holding Date
彭义兴限售股+流通A股24.70%30/09/2024
雷凤莲限售股+流通A股5.14%30/09/2024
彭海波限售股+流通A股4.77%30/09/2024
万小平限售股+流通A股3.28%30/09/2024
彭九莲限售股+流通A股1.79%30/09/2024
Company Secretary 刘明
Solicitors 北京市金杜律师事务所
Auditors 大信会计师事务所（特殊普通合伙）
Tel No 0791-85950380
Fax No 0791-85950380
Website www.sanxin-med.com
Email sanxinkeji1997@163.com;Lezr@163.com
Company Address
Register: 江西省南昌市南昌县小蓝经济开发区富山大道999号
Office: 江西省南昌市南昌县小蓝经济开发区富山大道999号
Listing Date 15/05/2015
Shares Capital
Shares Capital: 262,685,000
Total A Share: 262,685,000
Listed A Share: 175,261,530
Non-tradable A Share: 87,423,470
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.399
DPS(RMB)* ¥ 0.150
NBV Per Share(RMB)* ¥ 2.399
Market Capitalization(RMB) 2.766B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.